Navigation Links
Early Stage, Step 4: Cautionary trademark tales

Editor's note: This is the fourth in a series of articles on developing start-up companies in the technology or biotechnology sectors.

Madison, Wis. - In my last column for Stage 3, I indicated we would be moving on to forming the entity. In the meantime, I received a thoughtful response about the last column that bears addressing. As a remin......

Full article >>> inds me of a personal story from 25 years ago. My wife and I were driving to Dallas, Texas to visit my sisters. (This was before we had children and could take our sweet time getting to places.) We stopped in Wichita, Kan., to visit Wichita State University, where my wife got her master's degree in music piano perfor......

Full article >>> Wisconsin, so the Wichita trademark use never would have been problematic. The client might have considered licensing the name and collecting royalties from the outset since it really did not know whether it was going to extend its business beyond Wisconsin, much less to Kansas.

The reader made a good point. However, there is no easy answer. Of course, it often depends on which side of t......

Full article >>>
'"/>

Source:wistechnology.com By Joe Boucher 12/26/06


Related biology technology :

1. Early Stage: Step 11 - Other forms of finance
2. Early Stage 10: The nuances of federal laws
3. Early Stage, Step 9: Raising capital in the securities landscape
4. Early Stage, Step 8: Misclassifying workers brings risk
5. Early Stage 7, Part I: Just what is an employee?
6. Early Stage: Step 6 - Taxes, taxes, taxes!
7. Early Stage: Step 5 - Forming the entity
8. Early Stage, Step 3: Naming the entity
9. Early-stage quality brings investment, Meier says
10. Early-stage executives hear from investors
11. Early Stage Step 2: Choosing a domain name
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... Mass. , March 23, 2017 /PRNewswire/ ... partner to global in vitro diagnostics manufacturers ... of the industry,s first multiplexed Inherited ... disease testing by next-generation sequencing (NGS). The ... were developed with input from industry experts ...
(Date:3/23/2017)... , March 23, 2017 NetworkNewsWire ... ... death, putting significant strain on health care systems, in terms ... diagnoses rises, so too does the development of innovative and ... side effects. Among the many types of cancer treatments, a ...
(Date:3/22/2017)... TARRYTOWN, N.Y. , March 22, 2017 Regeneron ... among the Regeneron Genetics Center (RGC), U.K. Biobank and GSK ... in the U.K. Biobank resource. The initiative will enable researchers ... of new medicines for a wide range of serious and ... ...
(Date:3/22/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... ), a clinical-stage pharmaceutical company focused on the ... that Dr. Miriam Kidron , Oramed,s Chief ... Insulin for Diabetes Treatment: Bypassing the Roadblock," at ... Therapeutics (OPT) Boston Conference in Cambridge, Massachusetts ...
Breaking Biology Technology:
(Date:2/28/2017)... 27. Februar 2017  EyeLock LLC, ein marktführendes Unternehmen ... erstklassige biometrische Lösung zur Iris-Erkennung auf der ... LTE auf dem Mobile World Congress 2017 ... in Halle 3, Stand 3E10, vorstellen. ... Qualcomm Haven™ – eine Kombination aus Hardware, ...
(Date:2/22/2017)... -- With the biometrics market to exceed $10 ... that innovative and agile startups must incorporate into ... changing competitive landscape: multifactor authentication (MFA), point-of-sale (PoS), ... "Companies can no longer afford to cut corners ... Pavlakis , Industry Analyst at ABI Research. "Pairing ...
(Date:2/14/2017)... -- Wake Forest Baptist Medical Center today announced Julie Ann Freischlag, ... (CEO). Freischlag joins the medical center on May 1 ... who last year announced that he would transition to ... it since 2008.   As CEO, Freischlag ... academic health system, which includes Wake Forest School of ...
Breaking Biology News(10 mins):